Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
South Korea
· Delayed Price · Currency is KRW 2,725.00
-310.00 (-10.21%)
At close: Oct 11, 2024
Union Korea Pharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | -30,820 | -20,916 | -18,156 | -932.02 | -11,109 | Upgrade
|
| Depreciation & Amortization | 1,803 | 2,877 | 3,890 | 3,994 | 4,226 | Upgrade
|
| Loss (Gain) From Sale of Assets | -35.25 | -0.67 | -129.04 | - | -7.54 | Upgrade
|
| Asset Writedown & Restructuring Costs | 5,654 | 5,160 | 9,449 | - | 1,547 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -0.38 | Upgrade
|
| Loss (Gain) on Equity Investments | 518.08 | 23.89 | 19.46 | 5.47 | 9.88 | Upgrade
|
| Provision & Write-off of Bad Debts | 7,458 | -2,353 | -920.95 | -1,942 | -1,882 | Upgrade
|
| Other Operating Activities | 14,544 | 4,260 | 5,056 | 2,525 | 4,199 | Upgrade
|
| Change in Accounts Receivable | 3,987 | 16,592 | 373.21 | -4,996 | 1,288 | Upgrade
|
| Change in Inventory | 1,487 | -6,941 | 3,542 | -1,651 | 364.26 | Upgrade
|
| Change in Accounts Payable | -3,349 | 3,642 | -1,373 | -795.59 | 3,151 | Upgrade
|
| Change in Other Net Operating Assets | -2,381 | -1,922 | -387.99 | -1,271 | 128.6 | Upgrade
|
| Operating Cash Flow | -1,134 | 420.21 | 1,362 | -5,063 | 1,915 | Upgrade
|
| Operating Cash Flow Growth | - | -69.15% | - | - | - | Upgrade
|
| Capital Expenditures | -95.74 | -949.44 | -2,263 | -3,366 | -7,168 | Upgrade
|
| Sale of Property, Plant & Equipment | 48.99 | - | 10.27 | - | 23.44 | Upgrade
|
| Cash Acquisitions | - | - | -111.04 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -6.41 | -5.3 | 206.04 | -89 | -100 | Upgrade
|
| Investment in Securities | 1,181 | 128.33 | 49.99 | -72.81 | -828.4 | Upgrade
|
| Other Investing Activities | - | - | -0 | - | 0 | Upgrade
|
| Investing Cash Flow | 1,128 | -826.41 | -2,108 | -3,528 | -8,073 | Upgrade
|
| Short-Term Debt Issued | - | 3,000 | 15,332 | 3,500 | 3,000 | Upgrade
|
| Long-Term Debt Issued | - | 3,000 | 20,846 | - | 29,697 | Upgrade
|
| Total Debt Issued | - | 6,000 | 36,178 | 3,500 | 32,697 | Upgrade
|
| Short-Term Debt Repaid | -800 | -6,200 | -3,095 | -4,000 | -2,300 | Upgrade
|
| Long-Term Debt Repaid | -386.61 | -1,676 | -31,823 | -1,579 | -564.26 | Upgrade
|
| Total Debt Repaid | -1,187 | -7,876 | -34,919 | -5,579 | -2,864 | Upgrade
|
| Net Debt Issued (Repaid) | -1,187 | -1,876 | 1,260 | -2,079 | 29,833 | Upgrade
|
| Issuance of Common Stock | - | - | 28.37 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -2,717 | -4,592 | Upgrade
|
| Other Financing Activities | -0 | - | 50 | -1,229 | -0 | Upgrade
|
| Financing Cash Flow | -1,187 | -1,876 | 1,338 | -6,025 | 25,241 | Upgrade
|
| Foreign Exchange Rate Adjustments | -7.57 | 27.56 | -25.56 | -31.68 | 19.07 | Upgrade
|
| Net Cash Flow | -1,200 | -2,254 | 566.84 | -14,647 | 19,101 | Upgrade
|
| Free Cash Flow | -1,230 | -529.23 | -901.15 | -8,429 | -5,254 | Upgrade
|
| Free Cash Flow Margin | -3.38% | -1.03% | -1.43% | -13.75% | -10.88% | Upgrade
|
| Free Cash Flow Per Share | -170.11 | -73.22 | -124.80 | -1142.33 | -676.09 | Upgrade
|
| Cash Interest Paid | 507.14 | 901.99 | 621.78 | 595.25 | 448.98 | Upgrade
|
| Cash Income Tax Paid | -7.77 | -1.3 | 7.23 | -2.49 | -706.96 | Upgrade
|
| Levered Free Cash Flow | 6,913 | 13,375 | -7,528 | -13,368 | 7,871 | Upgrade
|
| Unlevered Free Cash Flow | 8,939 | 15,825 | -4,958 | -11,591 | 9,264 | Upgrade
|
| Change in Working Capital | -256.12 | 11,370 | 2,154 | -8,713 | 4,932 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.